Comparing Oral Chemotherapy Adherence for Health-System Versus Other Specialty Pharmacies
As medication cost skyrockets and the complexity of administration techniques increases, there is a greater need for specialty pharmacies. There are numerous specialty pharmacy models, including specialty pharmacies owned by large commercial pharmacy chains, pharmacies with pharmacy benefit managers (PBMs), and health system–owned specialty pharmacies. However, little is known about how effective these various practice models are in improving patient outcomes. Read more.

Drug Targets Against Oncogenic Drivers in Lung Cancer
Lung cancer remains one of the leading causes of cancer-related deaths in the United States. Approximately 60% of lung adenocarcinomas are associated with driver oncogenes. Among these oncogenes, epidermal growth factor receptor mutations, anaplastic lymphoma kinase rearrangements, and ROS1 proto-ongene rearrangements are found in 15% to 20%, 5% to 7%, and 1% of lung adenocarcinomas, respectively. Read more.

Developing an Ovarian Cancer Vaccine: Where Are We?
For much of 2020, the focus has been on developing a vaccine against SARS-CoV-2, the cause of COVID-19. However, vaccine research extends beyond trying to prevent infectious diseases and is also being studied as a tool in the prevention and management on oncological illnesses. There are currently 28 active clinical trials studying the potential efficacy of vaccines in ovarian cancer. Read more.